Stock Earnings

Question 1

United Therapeutics Corpの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、United Therapeutics Corpの総資産は$7,364で、純profitは$1,195です。

Question 2

UTHRの主要な財務比率は何ですか？

Accepted Answer

United Therapeutics Corpの流動比率は8、純利益率は41.53、1株当たり売上高は$59.31です。

Question 3

United Therapeutics Corpの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

United Therapeutics Corp largest revenue segment is Other, at a revenue of 22,100,000 in the most earnings release.For geography, United States is the primary market for United Therapeutics Corp, at a revenue of 2,739,700,000.

Question 4

United Therapeutics Corpは収益を上げていますか？

Accepted Answer

yes、最新の財務諸表によると、United Therapeutics Corpの純profitは$1,195です。

Question 5

United Therapeutics Corpに負債はありますか？

Accepted Answer

yes、United Therapeutics Corpの負債は920です。

Question 6

United Therapeutics Corpの発行済株式数は何株ですか？

Accepted Answer

United Therapeutics Corpの総発行済株式数は44.83株です。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	3,128	2,877	2,327	1,936	1,685	1,483
Revenue Growth (YoY)	14%	24%	20%	15%	14%	2%
Cost of Revenue	356	309	257	151	122	108
Gross Profit	2,771	2,567	2,070	1,784	1,563	1,375
Selling, General & Admin	705	638	473	470	464	423
Research & Development	544	481	408	322	410	357
Operating Expenses	1,249	1,119	881	793	874	781
Other Non Operating Income (Expenses)	8	14	1	-4	-8	104
Pretax Income	1,666	1,539	1,274	950	593	638
Income Tax Expense	394	343	289	223	118	124
Net Income	1,271	1,195	984	727	475	514
Net Income Growth	15%	21%	35%	53%	-8%	-594%
Shares Outstanding (Diluted)	47.3	48.5	49.7	48.5	47.3	44.6
Shares Change (YoY)	-2%	-2%	2%	3%	6%	2%
EPS (Diluted)	26.88	24.64	19.81	15	10.06	11.54
EPS Growth	17%	24%	32%	49%	-13%	-583%
Free Cash Flow	1,116	1,080	747	663	477	696
Free Cash Flow Per Share	23.59	22.26	15.03	13.67	10.08	15.6
Gross Margin	88.58%	89.22%	88.95%	92.14%	92.75%	92.71%
Operating Margin	48.65%	50.33%	51.05%	51.13%	40.83%	39.98%
Profit Margin	40.63%	41.53%	42.28%	37.55%	28.18%	34.65%
Free Cash Flow Margin	35.67%	37.53%	32.1%	34.24%	28.3%	46.93%
EBITDA	1,604	1,520	1,241	1,041	737	642
EBITDA Margin	51.27%	52.83%	53.33%	53.77%	43.73%	43.29%
D&A For EBITDA	82	72	53	51	49	49
EBIT	1,522	1,448	1,188	990	688	593
EBIT Margin	48.65%	50.33%	51.05%	51.13%	40.83%	39.98%
Effective Tax Rate	23.64%	22.28%	22.68%	23.47%	19.89%	19.43%

United Therapeutics Corp (UTHR) Price

UTHR Stock Price Chart

UTHR Income

Follow-Up Questions